| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...731811Z |
| P356 | DOI | 10.1371/JOURNAL.PONE.0031811 |
| P932 | PMC publication ID | 3288053 |
| P698 | PubMed publication ID | 22384078 |
| P5875 | ResearchGate publication ID | 221882678 |
| P50 | author | Mingyue Zheng | Q43370955 |
| P2093 | author name string | Yu Zhang | |
| Jing Chen | |||
| Lili Chen | |||
| Haitao Zhang | |||
| Hong Shen | |||
| Hualiang Jiang | |||
| Xu Shen | |||
| Lihong Hu | |||
| Chenjing Li | |||
| Jiming Ye | |||
| Xin-Gang Yao | |||
| P2860 | cites work | Mechanism by which metformin reduces glucose production in type 2 diabetes | Q22241286 |
| Insulin signalling and the regulation of glucose and lipid metabolism | Q24292020 | ||
| Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation | Q24322925 | ||
| Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid | Q24685517 | ||
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| Development of a novel GLUT4 translocation assay for identifying potential novel therapeutic targets for insulin sensitization | Q46227047 | ||
| Retinoic acids increase expression of GLUT4 in dedifferentiated and hypertrophied cardiac myocytes | Q46793314 | ||
| The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation | Q46827814 | ||
| Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. | Q52540333 | ||
| Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 | Q57976081 | ||
| Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate | Q71973575 | ||
| Differential interaction of steroid hormone receptors with LXXLL motifs in SRC-1a depends on residues flanking the motif | Q73580687 | ||
| Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation | Q79817052 | ||
| Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
| Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design | Q27748273 | ||
| Coot: model-building tools for molecular graphics | Q27860505 | ||
| Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver | Q28202134 | ||
| Regulated transport of the glucose transporter GLUT4 | Q28216848 | ||
| Structure, function, and regulation of the mammalian facilitative glucose transporter gene family | Q28292160 | ||
| PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene | Q28618806 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| The metabolic syndrome | Q29616309 | ||
| Coactivator and corepressor complexes in nuclear receptor function | Q29620132 | ||
| Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. | Q31843161 | ||
| Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). | Q34206633 | ||
| Peroxisome proliferator-activated receptor gamma and metabolic disease. | Q34275476 | ||
| Thiazolidinediones | Q34346862 | ||
| PPAR(gamma) and glucose homeostasis | Q34675958 | ||
| Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome | Q35753018 | ||
| Technology evaluation: ISIS-113715, Isis | Q35841339 | ||
| Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. | Q36011819 | ||
| Protein tyrosine phosphatases and signalling | Q36092317 | ||
| Retinoid x receptor heterodimers in the metabolic syndrome | Q36225102 | ||
| PTP1B as a drug target: recent developments in PTP1B inhibitor discovery | Q36805716 | ||
| Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking | Q36888387 | ||
| Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting | Q37598771 | ||
| Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations | Q39460118 | ||
| Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells | Q39653292 | ||
| Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter | Q39943738 | ||
| Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products | Q40396841 | ||
| Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner | Q40730870 | ||
| Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. | Q40999272 | ||
| GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay | Q41038402 | ||
| Retinoic acid stimulates glucose transporter expression in L6 muscle cells | Q41367863 | ||
| Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. | Q42225038 | ||
| Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha | Q42447473 | ||
| Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization | Q42818292 | ||
| Demonstration of insulin-responsive trafficking of GLUT4 and vpTR in fibroblasts | Q42834482 | ||
| PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle | Q42971374 | ||
| Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect | Q44460156 | ||
| Allosteric inhibition of protein tyrosine phosphatase 1B. | Q44982496 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | e31811 | |
| P577 | publication date | 2012-02-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | (+)-Rutamarin as a dual inducer of both GLUT4 translocation and expression efficiently ameliorates glucose homeostasis in insulin-resistant mice | |
| P478 | volume | 7 |
| Q37544369 | Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. |
| Q44017161 | Chalepin: A Compound from Ruta angustifolia L. Pers Exhibits Cell Cycle Arrest at S phase, Suppresses Nuclear Factor-Kappa B (NF-κB) Pathway, Signal Transducer and Activation of Transcription 3 (STAT3) Phosphorylation and Extrinsic Apoptotic Pathway |
| Q27680515 | Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor Ligand Binding Domain |
| Q28534604 | Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models |
| Q51149463 | Increasing the Level of IRS-1 and Insulin Pathway Sensitivity by Natural Product Carainterol A. |
| Q38313005 | Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice |
| Q34499394 | Phytochemicals from Ruta graveolens Activate TAS2R Bitter Taste Receptors and TRP Channels Involved in Gustation and Nociception. |
| Q38694918 | Rutamarin, an Active Constituent from Ruta angustifolia Pers., Induced Apoptotic Cell Death in the HT29 Colon Adenocarcinoma Cell Line |
Search more.